Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

NCT06734702 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

497

Enrollment

OTHER

Sponsor class

Conditions

Neoadjuvant Therapy
Concurrent Chemoradiotherapy
Immunotherapy
Locally Advanced Non-Small Cell Lung Cancer

Interventions

DRUG: Neoadjuvant therapy
RADIATION: Hypo-RT and concurrent chemotherapy
RADIATION: CFRT and concurrent chemotherapy
DRUG: Consolidative immunotherapy

Sponsor

Sun Yat-sen University